Authorized Generics May Draw More FTC Scrutiny, Expert Says

Drug Industry Daily
A A

Although an increasing number of generic drugmakers appear willing to participate in the authorized generics market, the controversial practice may soon face increased scrutiny from the FTC, according to an industry expert.

To View This Article:

Login

Subscribe To Drug Industry Daily